PHIA Brochure-FA · 2020. 2. 20. · Title: PHIA Brochure-FA Created Date: 4/19/2011 2:45:58 PM
Population-based HIV Impact Assessments (PHIA): An Introduction Focusing on Malawi and Zimbabwe...
-
Upload
hugh-hoover -
Category
Documents
-
view
217 -
download
0
Transcript of Population-based HIV Impact Assessments (PHIA): An Introduction Focusing on Malawi and Zimbabwe...
Population-based HIV Impact Assessments
(PHIA): An Introduction Focusing on
Malawi and Zimbabwe
Elizabeth Radin, PhD
Technical Specialist – Population-based SurveysProject Director, Malawi & Zimbabwe PHIAs
November 6, 2014
Presentation Objectives
1. Explain what ICAP’s PHIAs are2. Explain why ICAP is doing PHIAs from both a
SCIENTIFIC and POLICY perspective 3. Present how we are approaching the first two
PHIAs in Malawi and Zimbabwe4. Share information on the future of PHIAs at
ICAP
What are ICAP’s PHIAs
Population-based HIV Impact AssessmentA survey that is:• Nationally-led (MOH, NSO) • In collaboration with CDC• Cross-sectional• Household-based• Nationally and Sub-nationally Representative• Focused on impact-level indicators of the HIV
epidemic through biomarkers and self report
What we mean by ‘Impact Assessment’
IMPACTS
OUTCOMES
OUTPUTS
A Description of Impacts . . .
OUTPUT: product of activities(# of health staff trained)
IMPACT: long term, high-level result (reduced transmission, reduced mortality)
OUTCOME: medium-term result (# tested, # on ART)
What does a PHIA Assess?
• The currents status of the epidemic in a country
• The access to and uptake of HIV care and treatment services
Scientific Rationale for PHIAs
Health facilities, and health facility access exists in a spectrum . . .
ART Site VCT/ANC Health Center
Pharmacy Limited/No Access
Current data is largely facility-based
Facility-based data describes a subset of the population
It is difficult to infer population measures– such as prevalence or incidence – from facility based data
Population-based surveys are the gold standard for these indicators
Summary: Scientific Rationale
Policy Rationale for PHIAs
4 million
Num
ber o
n AR
T
El-Sadr WM et al 2012
Adults and children with HIV infection receiving ART with PEPFAR support, 2004-2011
2004 2011
Policy Rationale for PHIAs
After more than a decade of PEPFAR what is that status of the epidemic? For Example:• What is the rate of new infection following
prevention efforts?
• What is the proportion of Viral Load Suppression following expanded ART coverage?
Sampling for the PHIAsA Two-stage Cluster-based Sampling Strategy:
An example: What is the prevalence of coffee drinking at ICAP? Background: ICAP has 1000 staff, 20 Offices, 50 Staff/Office
A Census: Ask all 1000 ICAP staff if they drink coffee
A Simple Random Sample: Select 10, 100 or 500 ICAP staff and ask if they drink coffee
A Cluster-based Sample: Select 5 ICAP country offices, ask all staff in those offices if they drink coffee
A Two-stage Cluster-based Sample: Select 10 ICAP country offices, randomly select 25 people from each country office
Sampling for the PHIAsSampling Strategy:
• Using two-stage cluster-based sampling strategy– Sample ~500 Enumeration Areas (EA),stratified by health zone – Sample ~30 Households per EA
• Sample size includes ~15,000 HH; ~30,000 individuals
• Adults from every HH ~20,000, all children every other HH ~10,000
The DHS: A Pop Survey Celebrity
Similarities between DHS/PHIA
• Population-based household survey• Cross-sectional, nationally representative• Household and individual questionnaires• National and subnational HIV prevalence
estimates• Household and individual sample size similar
Differences between DHS & PHIA
• Biomarkers for CD4 counts, viral load, recency, drug resistance, ARV metabolites, peds
• Point-of-Care HIV testing and CD4 testing with return of results
• Opportunity to assess global HIV outcomes of interest that are outside domain of DHS– PMTCT – Potential for Treatment as Prevention
ICAP Experience with Pop Surveys• Swaziland HIV Incidence Measurement Survey • Sinazongwe Combination Prevention Evaluation
[SCOPE], in partnership with the Zambia MOH• Bukoba without New Infections, “Bukoba Bila
Maambukizi Mapya,” [BBM2] in Tanzania
Presentation Objective
MOH, CDC & ICAP’s Approach to Two PHIAs: Malawi and Zimbabwe
First Two PHIAs: Malawi and Zimbabwe
• In collaboration with CDC • Work with Ministries of Health to develop,
implement and disseminate findings from PHIA Pilots in Malawi in Zimbabwe
• From April 2014-March 2016• Currently in protocol development and pre-
implementation stage
Malawi• 16. 3 Million People
• Life expectancy: 54 Years
• Causes of Premature Mortality (YLL): HIV/AIDS (23.7%), Malaria (10%), Lower Respiratory Infection (9.7%)1
• HIV Prevalence (age 15-49)
• National: 10.3% 2
• HIV Care and Treatment:
• 675 ART sites, 470,000 patients on ART (83% of need)3
Malawi 2010 DHS.
1 Malawi Global Burden of Disease Study 2010; Institute for Health Metrics and Evaluation (IHME); 2 UNAIDS HIV and AIDS Estimates
3 UNGASS 2013 Malawi Country Progress Report
Zimbabwe• 13 Million People
• Life expectancy: 58 Years
• Causes of Premature Mortality (YLL): HIV/AIDS (29.0%), Lower respiratory infection (11.7%), Diarrheal disease (6.0%)1
• HIV Care and Treatment: 665,000 patients on ART (77% of need)2
Duri Kerina et al. HIV/AIDS: The Zimbabwean Situation and Trends. American Journal of Clinical Medicine Research, 2013, Vol. 1, No. 1.
1 Zimbabwe Global Burden of Disease Study 2010; Institute for Health Metrics and Evaluation (IHME); 2 UNGASS 2013 Zimbabwe Country Progress Report
Objectives for Malawi & Zimbabwe PHIAs
Primary Objectives:
• To estimate HIV incidence (i.e., prevalence of recent HIV infection) in a household-based, nationally representative sample of HIV-infected adults
• To estimate the sub-national prevalence of suppressed HIV viral load (<1000 cells/ml3) in a household-based, nationally representative sample of HIV-infected adults
Measuring Incidence LongitudinallyIncidence: new infections in a population
- --
---+-
January 1, 2014
= .25 cases per person year
January 1, 2015
Measuring Incidence Cross-Sectionally
2
1
Objective 1: IncidenceRecent infection (4-6 months) is identified by:
1) Low avidity - weak bonding strength between host antibody and virus.
2) An elevated level of HIV virus in the body
. . . And converted into an annualized rate
US HIV Incidence (06-09) = .02% Expected Zimbabwe/Malawi Incidence= ~1%
Objective 2: Viral Load Suppression (VLS)
0
10
20
30
40
50
60
70
80
90
100 HIV Treatment Cascade
% o
f all
peop
le w
ith H
IV
Adapted from: aids.gov/federal-resources/policies/care-continuum/
Objectives for Malawi & Zimbabwe PHIAs
• To estimate HIV incidence (i.e., prevalence of recent HIV infection) in a household-based, nationally representative sample of HIV-infected adults
• To estimate the sub-national prevalence of suppressed HIV viral load (<1000 cells/ml3) in a household-based, nationally representative sample of HIV-infected adults
Objectives for Malawi & Zimbabwe PHIAs
Secondary Objectives:
• HIV prevalence in adults and children• CD4 T-Cell counts• Transmitted drug resistance • ARV metabolites• Nutrition in HIV positive children• HIV-related risk behaviors • Use of HIV-related services• HIV knowledge and attitudes
Similarities in Malawi and Zimbabwe PHIAs
Objectives:• Incidence (national), Viral Load Suppression (zonal)
Eligibility Criteria:• Must be a HH member
– resides or slept night before in HH• Must give informed consent• All adults in every household• All children (ages 0-14) in every other household
Similarities in Malawi and Zimbabwe PHIAs
Survey Procedures: • Collect questionnaire data and blood samples • Carry out POC HIV and CD4 testing• Provide counseling and return results• Refer HIV positives to care• Transport blood samples to central lab for
additional testing
Similarities in Malawi and Zimbabwe PHIAs
Questionnaires:• Household Questionnaire • Adult Individual Questionnaire
– Demographics including marriage– HIV knowledge and attitudes– Reproduction– Sexual history– HIV testing, care and treatment history
Similarities in Malawi and Zimbabwe PHIAs
Data Management: • Tablets Cloud server in-country server
Laboratory Management:• Central level testing at a national lab (VL, EID, recency)
Country Oversight Mechanism:• TWG chaired by MOH • Sub-committees on Management, Protocol, Data,
Communications
Unique to Malawi PHIA
• Oversampling of high prevalence health zones – for greater precision around cascade analysis– interest in making programmatic
assessments/comparisons in future rounds
• Sample will include adults aged 15-64
Unique to ZIMPHIASecondary Objectives:• Prevalence of Syphilis• Describing the extent of stigma
Sampling:• Sample will include all adults over 15
Questionnaire:• Module for adolescents aged 10-14
Presentation Objective
The Future of PHIAs:The PHIA Project
On the Horizon: ‘the next 20’In collaboration with CDC and MOHs , ICAP will
conduct PHIAs in ~20 sub-Saharan African countries over the next 5 years
• No country list yet
Focus on building capacity for population-based surveys • Strengthen capacity in epidemiology, surveillance, statistics
and national reference laboratory services to collect, analyze, and use morbidity and mortality data
On the Horizon: ‘the next 20’• Partnerships with experienced groups:
– UCSF (KAIS), ICF (DHS), Westat (NHANES), SCHARP (e.g., HPTN/MTN/VTN and SHIMS) and ASLM
• Approach for high prevalence countries may differ for low prevalence countries
• Use results to assess impact of PEPFAR and guide policies and future programs
Key Messages• ICAP’s PHIAs are Population-based HIV Impact
Assessments
• Rigorously measure key indicators of the epidemic such as• Incidence• Viral Load Suppression
Key Messages• They will provide information on HIV program
effectiveness that can be used to inform future programs and policies
• The first two PHIAs will be in Malawi and Zimbabwe
• ICAP will work on ~20 PHIAs over the next 5 years
Acknowledgements
• The Governments of Malawi & Zimbabwe• United States Centers for Disease Control and
Prevention• The U.S. President’s Emergency Plan for AIDS
Relief (PEPFAR)• Padmaja Patnaik, Suzue Saito, Jessica Justman• The PHIA Team
Zikomo, Tatenda, Thank you!